Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
35.67
-1.74 (-4.65%)
At close: Aug 13, 2026, 4:00 PM EDT
35.91
+0.24 (0.67%)
Pre-market: Aug 14, 2026, 5:10 AM EDT
Parabilis Medicines Employees
Parabilis Medicines had 145 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
145
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,446,248
Market Cap
4.54B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 145 | 0 | - |
| Dec 31, 2025 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Denali Therapeutics | 507 |
| CRISPR Therapeutics AG | 393 |
| Dyne Therapeutics | 289 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
| Tango Therapeutics | 137 |
PBLS News
- 22 hours ago - Parabilis Medicines Slides: Corporate presentation - Filings
- 23 hours ago - Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 23 hours ago - Parabilis Medicines Earnings release: Q2 2026 - Filings
- 23 hours ago - Parabilis Medicines Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Parabilis Medicines initiated with an Outperform at Leerink - TheFly
- 5 weeks ago - Parabilis Medicines initiated with an Outperform at Evercore ISI - TheFly
- 5 weeks ago - Parabilis Medicines initiated with a Buy at BofA - TheFly
- 5 weeks ago - Parabilis Medicines initiated with a Buy at Guggenheim - TheFly